Comments by the manufacturer of Premarin®
Publisher
Springer Netherlands
Reference7 articles.
1. Ambrus J.L., Schimert G., Lajos T.Z., Ambrus C.M., Mink I.B., Lassman H.B., Moore R.H. and Melzer J. (1971) Effect of antifîbrinolytic agents and estrogens on blood loss and blood coagulation factors during open heart surgery. J. Med. 2, 65.
2. Elkeles R. S., Hampton J.R. and Michell J.R. A. (1968) Effect of oestrogens on human platelet behaviour. Lancet ii, 315.
3. Johnson J.F. (1957) Changes in plasma prothrombin, Ac-globulin and antithrombin concentration following intravenous administration of estrogens. Proc. Soc. exp. Biol. (N.Y.) 94, 92.
4. Schersten B. (1958) On haemostatics with particular reference to their clinical use. Sworn. Laak. 13, 855.
5. Schiff M. and Burn H.F. (1961) The effect of intravenous oestrogens on ground substance. Arch. Otolaryng. 73, 44.